Fifty percent reduction in non-HDLC concentration linked to reduced risk for CVD event by age 75 years
Recovery from metabolic syndrome is associated with a decreased risk for major adverse cardiovascular events, while increased risk is seen in association with MetS development.
Researchers identified a network of lipid species jointly associated with markers of both osteoporosis and atherosclerosis.
Statin therapy is not associated with increased decline in memory or cognition among older adults.
More than 12 percent of patients with atherosclerotic cardiovascular disease report nonadherence to medications due to costs.
Pooled data from a systematic review and meta-analysis indicated that supplementation with whey protein reduced individual components of metabolic syndrome.
For patients with ischemic stroke or transient ischemic attack with evidence of atherosclerosis, those with a target low-density lipoprotein cholesterol level of less than 70 mg/dL have a lower risk for cardiovascular events.
Breastfeeding for >12 months was found to be associated with a reduced risk for hypertension and diabetes.
Twice-yearly dosing with inclisiran sodium resulted in significant lowering of low-density lipoprotein cholesterol, according to results from the ORION-9 study.
Predictors of attaining low-density lipoprotein cholesterol and systolic blood pressure goals have been identified.
A high proportion of patients with atherosclerotic cardiovascular disease (ASCVD) do not achieve recommended low-density lipoprotein cholesterol.